Zollinger-Ellison syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (21 intermediate revisions by 3 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{MJK}} | {{CMG}} {{AE}} {{MJK}} | ||
==Overview== | ==Overview== | ||
The incidence of [[gastrinoma]], which can cause Zollinger-Ellison syndrome, is approximately 0. | The incidence of [[gastrinoma]], which can cause Zollinger-Ellison syndrome, is approximately 0.05 - 0.2 per 100,000 individuals worldwide. About 25 to 30 percent of [[Gastrinoma|gastrinomas]] are caused by [[multiple endocrine neoplasia type 1]] ([[MEN1]]). | ||
==Incidence== | |||
The incidence of [[ | ==Epidemiology and Demographics== | ||
==Age== | |||
Zollinger-Ellison syndrome | ===Incidence=== | ||
==Gender== | *The worldwide incidence of [[Gastrinoma|gastrinomas]] is about 5 to 30 cases per 100,000 individuals per year.<ref name="pmid28722872">{{cite journal |vauthors=Cingam SR, Karanchi H |title= |journal= |volume= |issue= |pages= |year= |pmid=28722872 |doi= |url=}}</ref> | ||
Males are more commonly affected with Zollinger-Ellison syndrome than females.<ref name="pmid17108778">{{cite journal| author=Berna MJ, Hoffmann KM, Serrano J, Gibril F, Jensen RT| title=Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature. | journal=Medicine (Baltimore) | year= 2006 | volume= 85 | issue= 6 | pages= 295-330 | pmid=17108778 | doi=10.1097/01.md.0000236956.74128.76 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17108778 }} </ref> | *With improved techniques for tumor detection, the annual incidence has increased. | ||
*About 80% to 90% of these tumors arise in the gastrinoma triangle. | |||
===Age=== | |||
*Zollinger-Ellison syndrome is a disease that tends to affect the middle-aged adult population (20 - 50 years of age).<ref name="pmid17108778">{{cite journal| author=Berna MJ, Hoffmann KM, Serrano J, Gibril F, Jensen RT| title=Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature. | journal=Medicine (Baltimore) | year= 2006 | volume= 85 | issue= 6 | pages= 295-330 | pmid=17108778 | doi=10.1097/01.md.0000236956.74128.76 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17108778 }} </ref> | |||
===Gender=== | |||
*Males are more commonly affected with Zollinger-Ellison syndrome than females.<ref name="pmid17108778">{{cite journal| author=Berna MJ, Hoffmann KM, Serrano J, Gibril F, Jensen RT| title=Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature. | journal=Medicine (Baltimore) | year= 2006 | volume= 85 | issue= 6 | pages= 295-330 | pmid=17108778 | doi=10.1097/01.md.0000236956.74128.76 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17108778 }} </ref> | |||
===Race=== | |||
*There is no racial predilection to Zollinger-Ellison syndrome | |||
==References== | ==References== | ||
Latest revision as of 15:12, 19 September 2019
|
Zollinger-Ellison syndrome Microchapters |
|
Differentiating Zollinger-Ellison syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Zollinger-Ellison syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Zollinger-Ellison syndrome epidemiology and demographics |
|
FDA on Zollinger-Ellison syndrome epidemiology and demographics |
|
CDC on Zollinger-Ellison syndrome epidemiology and demographics |
|
Zollinger-Ellison syndrome epidemiology and demographics in the news |
|
Blogs on Zollinger-Ellison syndrome epidemiology and demographics |
|
Risk calculators and risk factors for Zollinger-Ellison syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
The incidence of gastrinoma, which can cause Zollinger-Ellison syndrome, is approximately 0.05 - 0.2 per 100,000 individuals worldwide. About 25 to 30 percent of gastrinomas are caused by multiple endocrine neoplasia type 1 (MEN1).
Epidemiology and Demographics
Incidence
- The worldwide incidence of gastrinomas is about 5 to 30 cases per 100,000 individuals per year.[1]
- With improved techniques for tumor detection, the annual incidence has increased.
- About 80% to 90% of these tumors arise in the gastrinoma triangle.
Age
- Zollinger-Ellison syndrome is a disease that tends to affect the middle-aged adult population (20 - 50 years of age).[2]
Gender
- Males are more commonly affected with Zollinger-Ellison syndrome than females.[2]
Race
- There is no racial predilection to Zollinger-Ellison syndrome
References
- ↑ Cingam SR, Karanchi H. PMID 28722872. Missing or empty
|title=(help) - ↑ 2.0 2.1 Berna MJ, Hoffmann KM, Serrano J, Gibril F, Jensen RT (2006). "Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature". Medicine (Baltimore). 85 (6): 295–330. doi:10.1097/01.md.0000236956.74128.76. PMID 17108778.